| 摘要 |
Compositions for the therapeutic treatment of sleep apnoea contain 2-isopropyl-2,8-bis(3,4-dimethoxyphenyl)- 6-methyl-6-azaoctane nitrile, preferably in the form of the pharmacologically acceptable acid addition salts thereof (verapamil) as active substance.
<??>The compositions may also include triamterene and/or hydrochlorothiazide.
|
